March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session.
Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post a new 52-week low of $7.96 against a high of $24.38. The stock closed at $11.03 on Tuesday night. Volume rose to more than 8 million shares, about 20 times the daily average of about 430,000 shares traded. The tech services company’s corporate rating was dropped from ‘B1’ to ‘B2’ by Moody’s Investors Service this morning. The rating agency also put a negative outlook on the firm.
Celldex Therapeutics Inc. (NASDAQ: CLDX) posted a new 52-week low on Wednesday. Shares traded at a low of $3.45, down about 6.3%, after closing at $3.68 on Tuesday. The stock’s 52-week high is $32.82. Volume totaled about 20% above the daily average of around 3.3 million shares. The company said on Monday that it is discontinuing the phase 3 trials of its brain tumor vaccine and that took the stock down by more than half. Shares continue to slide but not plummet.
Osiris Therapeutics Inc. (NASDAQ: OSIR) dropped nearly 19% on Wednesday to post a new 52-week low of $5.25 against a 52-week high of $23.67. The stock closed at $6.46 on Tuesday night. Volume rose to nearly 2.5 million shares, more than 10 times the stock’s daily average volume of around 220,000. The company had no specific news today.
Dynavax Technologies Corp. (NASDAQ: DVAX) dropped by about 4.8% on Wednesday to post a new 52-week low at $15.80 after closing at $16.59 on Tuesday. The stock’s 52-week high is $32.49. Share volume was about equal to the daily average of around 1.2 million shares traded. The biopharma company’s shares recovered to trade up more than 2% near the end of the day Wednesday after missing revenue estimates when it reported earnings on Tuesday night.
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
